Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 11 893-900, Copyright © 1997 by American Association for Cancer Research

ARTICLES

A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China

YL Qiao, MS Tockman, L Li, YS Erozan, SX Yao, MJ Barrett, WH Zhou, CA Giffen, XC Luo and PR Taylor
Cancer Prevention Studies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

We initiated the present study to evaluate the accuracy of a new epithelial biomarker of early lung cancer. We tested the hypothesis that expression of a tumor-associated antigen by exfoliated sputum epithelial cells has greater accuracy (sensitivity and specificity) for the detection of preclinical, localized lung cancer than do routine clinical detection methods. Monoclonal antibody (MAb) 703D4 recognizes heterogeneous nuclear ribonuclear protein (hnRNP) A2/B1. We compared the accuracy of hnRNP up-regulation with cytology and radiographic screening for lung cancer detection in miners who were highly exposed to tobacco smoke, radon, and arsenic in southwestern China. The results showed that MAb 703D4 detection of hnRNP expression by sputum epithelial cells had greater accuracy for the detection of lung cancer than did routine screening methods, particularly for early (localized) disease. Among 57 cases and 76 noncases at the first screening, overall MAb detection of hnRNP was more sensitive (74 versus 21% for cytology and 42% for chest x-ray) but had lower specificity (70 versus 100% for cytology and 90% for chest x-ray) than standard methods. Recognizing hnRNP up-regulation resulted in detection of approximately one-third more early cases than did the combination of X-ray and cytology. Detection of hnRNP A2/B1 expression appears to be a good initial screening test for lung carcinogenesis, as it identified 74% of those who developed subsequent clinical lung cancer. Future studies might separate individuals with high lung cancer risk by MAb detection, confirming the positives with markers having greater specificity (e.g., clinical studies that become positive later in the morphological progression).

This article has been cited by other articles:

				S.-W. Kim, K. Cheon, C.-H. Kim, J.-H. Yoon, D. H. Hawke, R. Kobayashi, L. Prudkin, I. I. Wistuba, R. Lotan, W. K. Hong, et al. Proteomics-Based Identification of Proteins Secreted in Apical Surface Fluid of Squamous Metaplastic Human Tracheobronchial Epithelial Cells Cultured by Three-Dimensional Organotypic Air-Liquid Interface Method Cancer Res., July 15, 2007; 67(14): 6565 - 6573. [Abstract] [Full Text] [PDF]

				S. D. Spivack, G. J. Hurteau, R. Jain, S. V. Kumar, K. M. Aldous, J. F. Gierthy, and L. S. Kaminsky Gene-Environment Interaction Signatures by Quantitative mRNA Profiling in Exfoliated Buccal Mucosal Cells Cancer Res., September 15, 2004; 64(18): 6805 - 6813. [Abstract] [Full Text] [PDF]

				F B J M Thunnissen Sputum examination for early detection of lung cancer J. Clin. Pathol., November 1, 2003; 56(11): 805 - 810. [Abstract] [Full Text] [PDF]

				S. G. Spiro and J. C. Porter Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196. [Abstract] [Full Text] [PDF]

				F.R. Hirsch, D.T. Merrick, and W.A. Franklin Role of biomarkers for early detection of lung cancer and chemoprevention Eur. Respir. J., June 1, 2002; 19(6): 1151 - 1158. [Abstract] [Full Text] [PDF]

				K. S. Naunheim The right person for the job Ann. Thorac. Surg., June 1, 2000; 69(6): 1653 - 1654. [Full Text] [PDF]

				P. Fielding, L. Turnbull, W. Prime, M. Walshaw, and J. K. Field Heterogeneous Nuclear Ribonucleoprotein A2/B1 Up-Regulation in Bronchial Lavage Specimens: A Clinical Marker of Early Lung Cancer Detection Clin. Cancer Res., December 1, 1999; 5(12): 4048 - 4052. [Abstract] [Full Text] [PDF]

				J. L. Mulshine Reducing Lung Cancer Risk* : Early Detection Chest, December 1, 1999; 116(suppl_3): 493S - 496S. [Abstract] [Full Text] [PDF]

				R. J. Michelson, M. W. Collard, A. J. Ziemba, J. Persinger, B. Bartholomew, and J. I. Huggenvik Nuclear DEAF-1-related (NUDR) Protein Contains a Novel DNA Binding Domain and Represses Transcription of the Heterogeneous Nuclear Ribonucleoprotein A2/B1 Promoter J. Biol. Chem., October 22, 1999; 274(43): 30510 - 30519. [Abstract] [Full Text] [PDF]

				S. A. Ahrendt, J. T. Chow, L.-H. Xu, S. C. Yang, C. F. Eisenberger, M. Esteller, J. G. Herman, L. Wu, P. A. Decker, J. Jen, et al. Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer J Natl Cancer Inst, February 17, 1999; 91(4): 332 - 339. [Abstract] [Full Text] [PDF]